203 related articles for article (PubMed ID: 23785210)
1. Secondary infections, expanded tissue tropism, and evidence for malignant potential in immunocompromised mice infected with Mus musculus papillomavirus 1 DNA and virus.
Cladel NM; Budgeon LR; Cooper TK; Balogh KK; Hu J; Christensen ND
J Virol; 2013 Aug; 87(16):9391-5. PubMed ID: 23785210
[TBL] [Abstract][Full Text] [Related]
2. The Mouse Papillomavirus Infection Model.
Hu J; Cladel NM; Budgeon LR; Balogh KK; Christensen ND
Viruses; 2017 Aug; 9(9):. PubMed ID: 28867783
[TBL] [Abstract][Full Text] [Related]
3. Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.
Hu J; Budgeon LR; Cladel NM; Balogh K; Myers R; Cooper TK; Christensen ND
J Gen Virol; 2015 Dec; 96(12):3554-3565. PubMed ID: 26399579
[TBL] [Abstract][Full Text] [Related]
4. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
5. Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.
Spurgeon ME; Lambert PF
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051276
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
7. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
8. Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Brendle SA; Christensen ND; Schell TD; Hu J
Sci Rep; 2017 Dec; 7(1):16932. PubMed ID: 29208932
[TBL] [Abstract][Full Text] [Related]
9. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression.
Dorfer S; Strasser K; Schröckenfuchs G; Bonelli M; Bauer W; Kittler H; Cataisson C; Fischer MB; Lichtenberger BM; Handisurya A
Am J Transplant; 2021 Feb; 21(2):525-539. PubMed ID: 33063442
[TBL] [Abstract][Full Text] [Related]
10. Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models.
Cladel NM; Jiang P; Li JJ; Peng X; Cooper TK; Majerciak V; Balogh KK; Meyer TJ; Brendle SA; Budgeon LR; Shearer DA; Munden R; Cam M; Vallur R; Christensen ND; Zheng ZM; Hu J
Emerg Microbes Infect; 2019; 8(1):1108-1121. PubMed ID: 31340720
[TBL] [Abstract][Full Text] [Related]
11. Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.
Handisurya A; Day PM; Thompson CD; Buck CB; Kwak K; Roden RB; Lowy DR; Schiller JT
Virology; 2012 Nov; 433(2):385-94. PubMed ID: 22985477
[TBL] [Abstract][Full Text] [Related]
12. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients.
Švajdler M; Mezencev R; Kašpírková J; Kacerovská D; Kazakov DV; Ondič O; Michal M
Am J Dermatopathol; 2016 Oct; 38(10):751-7. PubMed ID: 26913849
[TBL] [Abstract][Full Text] [Related]
14. Mouse model of cervicovaginal papillomavirus infection.
Çuburu N; Cerio RJ; Thompson CD; Day PM
Methods Mol Biol; 2015; 1249():365-79. PubMed ID: 25348320
[TBL] [Abstract][Full Text] [Related]
15. A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Hu J; Christensen ND
PLoS One; 2015; 10(3):e0120128. PubMed ID: 25803616
[TBL] [Abstract][Full Text] [Related]
16. Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts.
Best SR; Esquivel D; Mellinger-Pilgrim R; Roden RBS; Pitman MJ
Laryngoscope; 2020 Mar; 130(3):712-717. PubMed ID: 31041820
[TBL] [Abstract][Full Text] [Related]
17. The Detection and Association of Canine Papillomavirus with Benign and Malignant Skin Lesions in Dogs.
Chang CY; Chen WT; Haga T; Yamashita N; Lee CF; Tsuzuki M; Chang HW
Viruses; 2020 Feb; 12(2):. PubMed ID: 32028559
[TBL] [Abstract][Full Text] [Related]
18. Optical imaging of HPV infection in a murine model.
Kines RC; Kobayashi H; Choyke PL; Bernardo ML
Methods Mol Biol; 2013; 961():141-50. PubMed ID: 23325640
[TBL] [Abstract][Full Text] [Related]
19. Animal models of papillomavirus pathogenesis.
Campo MS
Virus Res; 2002 Nov; 89(2):249-61. PubMed ID: 12445664
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in preclinical model systems for papillomaviruses.
Christensen ND; Budgeon LR; Cladel NM; Hu J
Virus Res; 2017 Mar; 231():108-118. PubMed ID: 27956145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
